CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.5728
-0.0104 (-1.78%)
At close: Aug 21, 2026, 4:00 PM EDT
0.5814
+0.0086 (1.50%)
After-hours: Aug 21, 2026, 6:48 PM EDT
CalciMedica Employees
CalciMedica had 16 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
16
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,327,500
Market Cap
19.56M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 16 | 0 | - |
| Dec 31, 2025 | 16 | 2 | 14.29% |
| Dec 31, 2024 | 14 | 2 | 16.67% |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Palatin Technologies | 29 |
| Cerenome | 28 |
| NewcelX | 12 |
| Tvardi Therapeutics | 12 |
| Cocrystal Pharma | 10 |
| Neuphoria Therapeutics | 8 |
| Lexaria Bioscience | 7 |
CALC News
- 2 days ago - CalciMedica initiated with a Buy at Guggenheim - TheFly
- 10 days ago - CalciMedica Quarterly report: Q2 2026 - Filings
- 23 days ago - CalciMedica announces FDA alignment on Phase 2b Auxora trial design - TheFly
- 23 days ago - CalciMedica, FDA alignment de-risks regulatory path, says H.C. Wainwright - TheFly
- 24 days ago - CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints - PRNewsWire
- 4 weeks ago - CalciMedica files to sell 56.02M shares of common stock for holders - TheFly
- 4 weeks ago - CalciMedica Registration statement: Registration filing - Filings
- 4 weeks ago - CalciMedica Proxy statement: Proxy filing - Filings